{"id":"NCT04296396","sponsor":"The George Washington University Biostatistics Center","briefTitle":"Opioid Prescription After Cesarean Trial","officialTitle":"Prescription After Cesarean Trial","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2020-09-21","primaryCompletion":"2022-04-07","completion":"2022-07-08","firstPosted":"2020-03-05","resultsPosted":"2023-10-03","lastUpdate":"2023-10-03"},"enrollment":5521,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"SINGLE","primaryPurpose":"TREATMENT"},"conditions":["Pregnancy Related","Opioid Use","Pain"],"interventions":[{"type":"DRUG","name":"0 to 20 tablets of oxycodone 5mg","otherNames":[]},{"type":"DRUG","name":"Fixed opioid prescription","otherNames":[]}],"arms":[{"label":"Individualized Opioid Prescription","type":"EXPERIMENTAL"},{"label":"Fixed Opioid Prescription","type":"OTHER"}],"summary":"Non-inferiority randomized trial of 5,500 women with a cesarean delivery randomized prior to discharge to either an individualized opioid prescription protocol (IOPP) that includes shared decision making or to a fixed opioid prescription of 20 tablets of oxycodone 5mg.","primaryOutcome":{"measure":"Number of Participants With Worst Pain Score of Moderate to Severe on the Brief Pain Inventory","timeFrame":"1 week post hospital discharge","effectByArm":[{"arm":"Individualized Opioid Prescription","deltaMin":1497,"sd":null},{"arm":"Fixed Opioid Prescription","deltaMin":1535,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":null}]},"eligibility":{"minAge":null,"sex":"FEMALE","healthyVolunteers":false,"inclusionCount":2,"exclusionCount":11},"locations":{"siteCount":12,"countries":["United States"]},"refs":{"pmids":["38857509"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":133,"n":2748},"commonTop":["Drowsiness"]}}